Value‑Based Contracting for Cell and Gene Therapies: A Scoping Review of Payer-Manufacturer Agreements and Treatment Center Considerations in the United States
- DOI
- 10.1016/j.jtct.2026.03.037
- Published
- 2026-08
- Container
- Transplantation and Cellular Therapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtct.2026.03.037,
title = {Value‑Based Contracting for Cell and Gene Therapies: A Scoping Review of Payer-Manufacturer Agreements and Treatment Center Considerations in the United States},
author = {Pranav M. Patel and Amy Heck Sheehan and Cynthia Wan and Jason B. Reed and Iulia Opran and Amber Small and Chelsea Phillips Renfro},
year = {2026},
journal = {Transplantation and Cellular Therapy},
doi = {10.1016/j.jtct.2026.03.037},
url = {https://doi.org/10.1016/j.jtct.2026.03.037}
}RIS
TY - JOUR TI - Value‑Based Contracting for Cell and Gene Therapies: A Scoping Review of Payer-Manufacturer Agreements and Treatment Center Considerations in the United States AU - Pranav M. Patel AU - Amy Heck Sheehan AU - Cynthia Wan AU - Jason B. Reed AU - Iulia Opran AU - Amber Small AU - Chelsea Phillips Renfro PY - 2026 JO - Transplantation and Cellular Therapy DO - 10.1016/j.jtct.2026.03.037 UR - https://doi.org/10.1016/j.jtct.2026.03.037 ER -
APA
Patel, P. M., Sheehan, A. H., Wan, C., Reed, J. B., Opran, I., Small, A., & Renfro, C. P. (2026). Value‑Based Contracting for Cell and Gene Therapies: A Scoping Review of Payer-Manufacturer Agreements and Treatment Center Considerations in the United States. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2026.03.037
Source records
- crossref · retrieved 2026-09-25T15:16:30.371Z